Results 321 to 330 of about 1,516,429 (359)

EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS

Retina, 2004
Intravitreous (i.v.t.) injection is increasingly being incorporated into the management of ocular diseases. While only fomivirsen sodium (Vitravene) is currently approved by the Food and Drug Administration as an i.v.t. injection, the number of approved i.v.t.
Harry W. Flynn, Stanley Chang, Terrence P. O'Brien, Steve Hutcherson, Michael T. Trese, Richard F. Spaide, Christopher N. Ta, Alexander J. Brucker, Jeffrey M. Liebmann, Lisa R. Grillone, Donald J. D'Amico, Emmett T. Cunningham, Ingrid U. Scott, Lloyd Paul Aiello   +13 more
openaire   +2 more sources

OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC

Retina, 2017
Purpose: To examine the safety outcomes of an intravitreal injection-only clinic where patients needing long-term anti-vascular endothelial growth factor therapy are treated with injections at a predetermined interval for a set number of injections without an accompanying clinic visit. Methods:
Elizabeth A. Atchison, Sophie J. Bakri, Raymond Iezzi, Andrew J. Barkmeier, Ahmed F. Omar   +4 more
openaire   +2 more sources

Intravitreal Injection of Octreotide Acetate

Journal of Ocular Pharmacology and Therapeutics, 1997
This study was conducted to determine the feasibility of injecting the somatostatin analogue, octreotide acetate (OA), into the vitreous cavity. Previous work suggests that octreotide effectively inhibits angiogenesis in vitro, thus its use in vivo may slow the progression of proliferative eye disease.
Kevin L. Winthrop, Thomas M. O'Dorisio, Igor Westra, Joseph E. Robertson, Rosemary Barrie, Douglas B. Holmes, Eugene A. Woltering   +6 more
openaire   +3 more sources

Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections.

Developments in ophthalmology, 2016
The advantage of intravitreal injections is an immediate and increased therapeutic effect in the intended retinal tissue. The accuracy, precision and reproducibility of the delivered volume depend on the size of the syringe and the physician's manual ...
C. Meyer, T. Krohne, P. Charbel Issa, Zengping Liu, F. Holz   +4 more
semanticscholar   +1 more source

INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS

Retina, 2009
Intravitreal injection (IVI) with administration of various pharmacological agents is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related macular degeneration, cystoid macular edema, diabetic retinopathy, uveitis, vascular occlusions, and retinal detachment.
Eleonora M. Lad, Darius M. Moshfeghi, Gholam A. Peyman   +2 more
openaire   +2 more sources

Preclinical PET Study of Intravitreal Injections.

Investigative Ophthalmology and Visual Science, 2017
Purpose This work aimed at describing the time course of vitreous clearance through the use of positron emission tomography (PET) as a noninvasive tool for pharmacokinetic studies of intravitreal injection.
A. Fernández‐Ferreiro, A. Luaces-Rodríguez, P. Aguiar, J. Pardo-Montero, M. González-Barcia, Lara García-Varela, M. Herranz, J. Silva-Rodríguez, M. Gil-Martínez, M. Bermudez, Alba Vieites-Prado, J. Blanco-Méndez, M. Lamas, F. Gómez-Ulla, Á. Ruibal, F. Otero-Espinar, Francisco Gonzalez   +16 more
semanticscholar   +1 more source

Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.

Ophthalmic Surgery Lasers and Imaging Retina, 2015
BACKGROUND AND OBJECTIVE To assess the incidence and outcomes of infectious endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents.
N. Gregori, H. Flynn, S. G. Schwartz, P. Rosenfeld, Kamyar Vaziri, A. Moshfeghi, J. Fortun, Jaclyn L Kovach, Sander R. Dubovy, T. Albini, Janet L. Davis, A. Berrocal, W. Smiddy   +12 more
semanticscholar   +1 more source

Scleral thinning after repeated intravitreal injections of antivascular endothelial growth factor agents in the same quadrant.

Investigative Ophthalmology and Visual Science, 2015
PURPOSE We assessed the effects of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy on scleral architecture using spectral domain anterior segment optical coherence tomography (OCT).
M. Zinkernagel, P. Schorno, A. Ebneter, S. Wolf   +3 more
semanticscholar   +1 more source

Complications of intravitreal steroid injections

Optometry - Journal of the American Optometric Association, 2005
Intravitreal corticosteroid injections are a new therapeutic procedure used to treat various retinal edematous and neovascular conditions. They have been used in the treatment of diabetic macular edema, exudative macular degeneration, pseudophakic cystoid macular edema, macular edema associated with retinal vein occlusion, and chronic uveitis as well ...
openaire   +3 more sources

Complications of Intravitreous Injections in Patients with Diabetes

Seminars in Ophthalmology, 2014
Intravitreal injections for the treatment of retinal disorders and intraocular infection have become a common ophthalmic procedure, and injections of anti-vascular endothelial growth factor agents or steroids are frequently performed for the treatment of diabetic macular edema or other diabetic vascular pathology.
Paolo S. Silva, Hasanain Shikari, Jennifer K. Sun   +2 more
openaire   +4 more sources